Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve

scientific article published in July 2001

Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1006/EXNR.2001.7673
P698PubMed publication ID11421592

P2093author name stringHohman TC
Helke CJ
Lee PG
Cai F
Regalia J
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)149-161
P577publication date2001-07-01
P1433published inExperimental NeurologyQ5421127
P1476titleStreptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve
P478volume170

Reverse relations

cites work (P2860)
Q44318970Abnormal PI3 kinase/Akt signal pathway in vagal afferent neurons and vagus nerve of streptozotocin-diabetic rats
Q34574725Age-dependent slowing of enteric axonal transport in insulin-resistant mice
Q34545203Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far.
Q30384107Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.
Q28567468Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus
Q47339666Diabetic autonomic neuropathy: evidence for apoptosis in situ in the rat.
Q37038404Glucose neurotoxicity
Q90020621Impairment of Axonal Transport in Diabetes: Focus on the Putative Mechanisms Underlying Peripheral and Central Neuropathies
Q36836634Mechanisms of disease: the pathological basis of gastroparesis--a review of experimental and clinical studies
Q37342719Modulation of gastrointestinal vagal neurocircuits by hyperglycemia
Q35196483Musings on the wanderer: what's new in our understanding of vago-vagal reflexes? V. Remodeling of vagus and enteric neural circuitry after vagal injury.
Q35184731Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes.
Q34800404Neuropathology and pathogenesis of diabetic autonomic neuropathy
Q37049189Neurotrophic factors in autonomic nervous system plasticity and dysfunction
Q45159181Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats
Q40666489Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice
Q44006652Streptozotocin-induced diabetes and the neurochemistry of vagal afferent neurons
Q44006706Streptozotocin-induced diabetes reduces retrograde axonal transport in the afferent and efferent vagus nerve
Q48155108The effects of deafferentation and exogenous NGF on neurotrophins and neurotrophin receptor mRNA expression in the adult superior cervical ganglion
Q36762639The therapeutic potential of gene transfer for the treatment of peripheral neuropathies
Q28580655Treadmill exercise improves cognitive function and facilitates nerve growth factor signaling by activating mitogen-activated protein kinase/extracellular signal-regulated kinase1/2 in the streptozotocin-induced diabetic rat hippocampus
Q81477359Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes
Q44654054α-Lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats

Search more.